<DOC>
	<DOC>NCT00085761</DOC>
	<brief_summary>The purpose of the study is to determine if an investigational drug, NGX-4010 (high-concentration capsaicin patch), is safe, tolerable and effective in treating painful HIV-associated neuropathy.</brief_summary>
	<brief_title>Study of NGX-4010 for Treatment of Painful HIV-Associated Neuropathy</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Nervous System Diseases</mesh_term>
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Capsaicin</mesh_term>
	<criteria>Key Eligibility Criteria: Must have had HIVassociated neuropathy for at least 2 months, with moderate to severe pain in both feet. Must not have significant pain in feet due to other causes (for example, arthritis). Must have intact skin at the treatment area. Must be prepared to remain on the same pain medications at the same doses as before the study for the entire duration of the study (12 weeks). Must not use topical pain medications for HIVassociated neuropathy. Must be able to comply with study requirements such as completing daily pain diary and attending study visits. Must be at least 18 years old, not pregnant, and be able to take care of self independently, with only occasional assistance if needed. No significant medical problems of the heart, kidneys, liver or lungs, or cancer. No history or current problem with substance abuse.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2008</verification_date>
	<keyword>Dermal assessment</keyword>
	<keyword>Pain measurement</keyword>
	<keyword>Diary</keyword>
	<keyword>Neuropathy</keyword>
	<keyword>Analgesics/*therapeutic use</keyword>
	<keyword>Capsaicin/*administration &amp; dosage/adverse effects</keyword>
	<keyword>HIV Infections/*complications/*drug therapy</keyword>
	<keyword>Pain</keyword>
	<keyword>Complementary Therapies</keyword>
</DOC>